Literature DB >> 8181295

Hemodynamic effects of intravenous pyruvate in the intact, anesthetized dog.

J Yanos1, M J Patti, R T Stanko.   

Abstract

OBJECTIVES: There is evidence from human studies that pyruvate improves skeletal muscle endurance, and from isolated heart preparations that pyruvate is a positive inotrope. We examined the hemodynamic effects of intravenous pyruvate in an intact, anesthetized dog preparation in order to test its effects in an intact animal. Our hypothesis was that pyruvate is a positive inotrope in the intact dog.
DESIGN: Prospective, randomized, controlled trial.
SETTING: Animal laboratory.
SUBJECTS: Ten mongrel dogs.
INTERVENTIONS: Two groups of animals were anesthetized with chloralose and urethane, mechanically ventilated, and hemodynamically monitored. The experimental group (n = 6) received an infusion of calcium pyruvate and sodium pyruvate, while the control group (n = 4) received an infusion of calcium chloride and sodium chloride.
MEASUREMENTS AND MAIN RESULTS: The intravenous infusion of calcium and sodium pyruvate resulted in increased cardiac output, left ventricular contractility, and mixed venous oxygen saturation values in the experimental group compared with the control group of four dogs. There were no significant detrimental effects except an increase in the mean serum calcium concentrations in both groups.
CONCLUSIONS: These data suggest that intravenous pyruvate may be a useful in vivo positive inotrope.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8181295     DOI: 10.1097/00003246-199405000-00022

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  Competition of pyruvate with physiological substrates for oxidation by the heart: implications for studies with hyperpolarized [1-13C]pyruvate.

Authors:  Karlos X Moreno; Scott M Sabelhaus; Matthew E Merritt; A Dean Sherry; Craig R Malloy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-05       Impact factor: 4.733

2.  Ringer's ethyl pyruvate solution attenuates hypoperfusion and renal injury after multivisceral ischemia-reperfusion in rabbits.

Authors:  Takashige Yamada; Daisuke Nishimura; Kei Inoue; Jungo Kato; Hiroshi Morisaki; Yoshifumi Kotake
Journal:  J Anesth       Date:  2020-01-09       Impact factor: 2.078

3.  Pyruvate modulates cardiac sarcoplasmic reticulum Ca2+ release in rats via mitochondria-dependent and -independent mechanisms.

Authors:  Aleksey V Zima; Jens Kockskämper; Rafael Mejia-Alvarez; Lothar A Blatter
Journal:  J Physiol       Date:  2003-06-24       Impact factor: 5.182

4.  Intracoronary pyruvate in cardiogenic shock as an adjunctive therapy to catecholamines and intra-aortic balloon pump shows beneficial effects on hemodynamics.

Authors:  Wolfgang Schillinger; Mark Hünlich; Samuel Sossalla; Hans-Peter Hermann; Gerd Hasenfuss
Journal:  Clin Res Cardiol       Date:  2010-12-04       Impact factor: 5.460

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.